Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Phillips 66 price target lowered to $76 from $84 at Piper Sandler » 06:06
11/13/20
11/13
06:06
11/13/20
06:06
PSX

Phillips 66

$54.85 /

-4.02 (-6.83%)

Piper Sandler analyst…

Piper Sandler analyst Ryan Todd lowered the firm's price target on Phillips 66 to $76 from $84 and keeps an Overweight rating on the shares. The analyst says despite near-term headwinds through the first half of 2021 on a potential COVID-driven pullback in demand, improved visibility on the recovery from vaccine readiness and refinery closures makes him "cautiously optimistic" on the outlook for refiners in the second half of 2021.

ShowHide Related Items >><<
PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

11/05/20 Wolfe Research
Phillips 66 upgraded to Outperform from Peer Perform at Wolfe Research
10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

PSX Phillips 66
$54.85 /

-4.02 (-6.83%)

Options
Phillips 66 call volume above normal and directionally bullish » 14:25
11/09/20
11/09
14:25
11/09/20
14:25
PSX

Phillips 66

$57.82 /

+11.125 (+23.83%)

Bullish option flow…

Bullish option flow detected in Phillips 66 with 14,929 calls trading, 6x expected, and implied vol increasing almost 4 points to 53.72%. Feb-21 55 calls and Dec-20 50 calls are the most active options, with total volume in those strikes near 4,700 contracts. The Put/Call Ratio is 0.23. Earnings are expected on January 29th.

ShowHide Related Items >><<
PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

11/05/20 Wolfe Research
Phillips 66 upgraded to Outperform from Peer Perform at Wolfe Research
10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

PSX Phillips 66
$57.82 /

+11.125 (+23.83%)

Upgrade
Phillips 66 upgraded to Outperform from Peer Perform at Wolfe Research » 09:31
11/05/20
11/05
09:31
11/05/20
09:31
PSX

Phillips 66

$47.91 /

+0.36 (+0.76%)

Wolfe Research analyst…

Wolfe Research analyst Sam Margolin upgraded Phillips 66 to Outperform from Peer Perform with an unchanged price target of $63.

ShowHide Related Items >><<
PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

PSX Phillips 66
$47.91 /

+0.36 (+0.76%)

Options
Phillips 66 put volume heavy and directionally bearish » 13:35
10/30/20
10/30
13:35
10/30/20
13:35
PSX

Phillips 66

$45.45 /

-0.54 (-1.17%)

Bearish flow noted in…

Bearish flow noted in Phillips 66 with 3,894 puts trading, or 3x expected. Most active are Dec-20 45 puts and Dec-20 42.5 puts, with total volume in those strikes near 2,100 contracts. The Put/Call Ratio is 1.99, while ATM IV is up nearly 2 points on the day. Earnings are expected on October 30th.

ShowHide Related Items >><<
PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

PSX Phillips 66
$45.45 /

-0.54 (-1.17%)

Earnings
Phillips 66 reports Q3 adj. EPS (1c), consensus (79c) » 07:12
10/30/20
10/30
07:12
10/30/20
07:12
PSX

Phillips 66

$45.99 /

+1.84 (+4.17%)

Phillips 66 generated…

Phillips 66 generated $491M in cash from operations during the third quarter, including $305M of cash distributions from equity affiliates. Excluding working capital impacts, operating cash flow was $795M. "Our diversified, integrated portfolio helped us navigate a challenging market environment in the third quarter," said Greg Garland, chairman and CEO of Phillips 66. "Our Midstream, Chemicals and Marketing businesses benefited from improved market conditions, while Refining continued to be impacted by weak margins. We advanced our growth strategy with the recent startup of Sweeny Fracs 2 and 3, marking completion of the Sweeny Hub phase 2 expansion. Also, we announced Rodeo Renewed, a project to reconfigure our San Francisco Refinery into the world's largest renewable fuels plant, making investments that advance a lower carbon future.

ShowHide Related Items >><<
PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

PSX Phillips 66
$45.99 /

+1.84 (+4.17%)

Options
Phillips 66 call volume above normal and directionally bullish » 11:45
10/27/20
10/27
11:45
10/27/20
11:45
PSX

Phillips 66

$47.86 /

-0.28 (-0.58%)

Bullish option flow…

Bullish option flow detected in Phillips 66 with 1,781 calls trading, 1.3x expected, and implied vol increasing over 1 point to 53.87%. Feb-21 55 calls and 11/6 weekly 52.5 calls are the most active options, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 0.64. Earnings are expected on October 30th.

ShowHide Related Items >><<
PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

10/22/20 Mizuho
Phillips 66 price target lowered to $70 from $92 at Mizuho
10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

PSX Phillips 66
$47.86 /

-0.28 (-0.58%)

Over a month ago
Recommendations
Phillips 66 price target lowered to $70 from $92 at Mizuho » 06:48
10/22/20
10/22
06:48
10/22/20
06:48
PSX

Phillips 66

$48.71 /

-0.88 (-1.77%)

Mizuho analyst Silvio…

Mizuho analyst Silvio Micheloto lowered the firm's price target on Phillips 66 to $70 from $92 and keeps a Buy rating on the shares. The analyst cut estimates and price targets in the refiners space to reflect weaker crack spreads and slower demand recovery than previously anticipated.

ShowHide Related Items >><<
PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
07/22/20 Wells Fargo
Phillips 66 Partners downgraded to Equal Weight from Overweight at Wells Fargo
PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

PSX Phillips 66
$48.71 /

-0.88 (-1.77%)

Hot Stocks
Chevron Phillips Chemical completes first scale production of polyethylene » 08:16
10/08/20
10/08
08:16
10/08/20
08:16
CVX

Chevron

$73.78 /

+1.48 (+2.05%)

, PSX

Phillips 66

$51.95 /

+0.9 (+1.76%)

Chevron Phillips…

Chevron Phillips Chemical, equally owned indirectly by Chevron (CVX) and Phillips 66 (PSX), announced success in its first commercial scale production of polyethylene using advanced recycling technology. Advanced recycling, sometimes referred to as "chemical recycling," converts plastic waste to valuable liquids that can become new petrochemicals. This approach complements traditional recycling by converting a range of materials, including many difficult-to-recycle plastics, into important building blocks for new chemicals. Because of the potential to repeatedly recycle post-use plastics into new materials, polymers produced through advanced recycling are often referred to as "circular polymers." Chevron Phillips Chemical's circular polyethylene matches the performance and safety specifications of the virgin polymers Chevron Phillips Chemical is known for globally. Commercial scale production is a result of the company's two-year exploration into the technical viability of creating circular polymers from waste plastics. Chevron Phillips Chemical is now working on scaling up its production of circular polyethylene to meet its ambitious production plans. That includes working with several proven suppliers of pyrolysis oil, the feedstock made from waste plastics, and pursuing certification for the new polyethylene through the International Sustainability and Carbon Certification Plus approach using their mass balance certification methodology.

ShowHide Related Items >><<
PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

09/28/20 BofA
Chevron upgraded to Buy from Neutral at BofA
09/25/20 Morgan Stanley
Noble Midstream initiated with an Underweight at Morgan Stanley
09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/23/20 MKM Partners
Chevron initiated with a Buy at MKM Partners
PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

10/06/20 Barclays
Phillips 66 price target lowered to $64 from $73 at Barclays
09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
07/22/20 Wells Fargo
Phillips 66 Partners downgraded to Equal Weight from Overweight at Wells Fargo
PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

PSX Phillips 66
$51.95 /

+0.9 (+1.76%)

CVX Chevron
$73.78 /

+1.48 (+2.05%)

Recommendations
Phillips 66 price target lowered to $64 from $73 at Barclays » 06:07
10/06/20
10/06
06:07
10/06/20
06:07
PSX

Phillips 66

$52.56 /

+1.525 (+2.99%)

Barclays analyst Theresa…

Barclays analyst Theresa Chen lowered the firm's price target on Phillips 66 to $64 from $73 and keeps an Overweight rating on the shares. Despite higher refining throughput quarter-over-quarter, the analyst looks for capture to worsen due to lower secondary product margins, narrower differentials, and lower optimization ahead of Hurricanes Laura and Sally.

ShowHide Related Items >><<
PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
07/22/20 Wells Fargo
Phillips 66 Partners downgraded to Equal Weight from Overweight at Wells Fargo
07/20/20 Jefferies
Phillips 66 upgraded to Buy at Jefferies following pullback
PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

PSX Phillips 66
$52.56 /

+1.525 (+2.99%)

On The Fly
Week in review: How Trump's policies moved stocks » 09:23
09/19/20
09/19
09:23
09/19/20
09:23
AZN

AstraZeneca

$56.47 /

+0.53 (+0.95%)

, BMY

Bristol-Myers

$59.26 /

-0.14 (-0.24%)

, LLY

Eli Lilly

$154.23 /

+1.74 (+1.14%)

, GSK

GlaxoSmithKline

$39.26 /

-0.2 (-0.51%)

, JNJ

Johnson & Johnson

$149.12 /

+2.03 (+1.38%)

, MRK

Merck

$85.82 /

+0.17 (+0.20%)

, NVS

Novartis

$90.92 /

+0.07 (+0.08%)

, PFE

Pfizer

$36.61 /

-0.2 (-0.54%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$52.42 /

+0.34 (+0.65%)

, ORCL

Oracle

$59.77 /

-0.43 (-0.71%)

, WMT

Walmart

$135.30 /

-1.39 (-1.02%)

, DK

Delek US

$11.89 /

-0.2 (-1.65%)

, HFC

HollyFrontier

$22.00 /

-0.26 (-1.17%)

, MPC

Marathon Petroleum

$32.26 /

+0.14 (+0.44%)

, PSX

Phillips 66

$59.83 /

-0.51 (-0.85%)

, TSO

Tesoro

$0.00 /

+ (+0.00%)

, VLO

Valero

$48.77 /

-0.23 (-0.47%)

, WNR

Western Refining

$0.00 /

+ (+0.00%)

, FB

Facebook

$252.53 /

-2.49 (-0.98%)

Catch up on the top…

ShowHide Related Items >><<
WMT Walmart
$135.30 /

-1.39 (-1.02%)

VLO Valero
$48.77 /

-0.23 (-0.47%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PSX Phillips 66
$59.83 /

-0.51 (-0.85%)

PFE Pfizer
$36.61 /

-0.2 (-0.54%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

HFC HollyFrontier
$22.00 /

-0.26 (-1.17%)

GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

DK Delek US
$11.89 /

-0.2 (-1.65%)

BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

09/18/20 Societe Generale
GlaxoSmithKline price target raised to 2,350 GBp at Societe Generale
09/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,650 GBp from 1,700 GBp at JPMorgan
09/01/20 AlphaValue
GlaxoSmithKline upgraded to Buy from Add at AlphaValue
09/01/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,700 GBp from 1,725 GBp at Morgan Stanley
JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
NVS Novartis
$90.92 /

+0.07 (+0.08%)

09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
PFE Pfizer
$36.61 /

-0.2 (-0.54%)

09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 JMP Securities
Trillium Therapeutics price target raised to $14 from $10 at JMP Securities
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
SNY Sanofi
$52.42 /

+0.34 (+0.65%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
WMT Walmart
$135.30 /

-1.39 (-1.02%)

09/18/20 Cleveland Research
Walmart U.S. sales appear directionally better recently, says Cleveland Research
09/03/20 KeyBanc
Inovalon price target raised to $29 from $24 at KeyBanc
09/03/20 Bernstein
Walmart+ 'a bit rushed,' Walmart still best deal on grocery, says Bernstein
09/02/20 Morgan Stanley
Oak Street deal with Walmart an incremental opportunity, says Morgan Stanley
DK Delek US
$11.89 /

-0.2 (-1.65%)

09/11/20 JPMorgan
Delek US price target lowered to $13 from $19 at JPMorgan
08/06/20 Scotiabank
Scotiabank downgrades Delek to Underperform on near-term negative catalysts
08/06/20 Scotiabank
Delek US downgraded to Underperform from Sector Perform at Scotiabank
07/09/20 Tudor Pickering
Delek US upgraded to Hold from Sell at Tudor Pickering
HFC HollyFrontier
$22.00 /

-0.26 (-1.17%)

09/11/20 JPMorgan
HollyFrontier price target lowered to $28 from $34 at JPMorgan
08/07/20 Goldman Sachs
HollyFrontier upgraded to Neutral from Sell at Goldman Sachs
07/22/20 Mizuho
HollyFrontier downgraded to Neutral on higher spending at Mizuho
07/22/20 Mizuho
HollyFrontier downgraded to Neutral from Buy at Mizuho
MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

09/11/20 JPMorgan
Marathon Petroleum price target lowered to $37 from $44 at JPMorgan
08/12/20 Cowen
Marathon Petroleum upgraded to Outperform from Market Perform at Cowen
08/04/20 Tudor Pickering
Marathon Petroleum downgraded to Sell from Buy at Tudor Pickering
08/03/20 Morgan Stanley
Marathon sale of Speedway for $21B a 'positive outcome,' says Morgan Stanley
PSX Phillips 66
$59.83 /

-0.51 (-0.85%)

09/11/20 JPMorgan
Phillips 66 price target lowered to $75 from $79 at JPMorgan
08/25/20 Raymond James
Phillips 66 price target lowered to $75 from $80 at Raymond James
07/22/20 Wells Fargo
Phillips 66 Partners downgraded to Equal Weight from Overweight at Wells Fargo
07/20/20 Jefferies
Phillips 66 upgraded to Buy at Jefferies following pullback
TSO Tesoro
$0.00 /

+ (+0.00%)

VLO Valero
$48.77 /

-0.23 (-0.47%)

09/11/20 JPMorgan
Valero price target lowered to $59 from $68 at JPMorgan
08/25/20 Raymond James
Valero price target lowered to $63 from $69 at Raymond James
07/20/20 Jefferies
Valero upgraded to Buy at Jefferies following pullback
07/20/20 Jefferies
Valero upgraded to Buy from Hold at Jefferies
WNR Western Refining
$0.00 /

+ (+0.00%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

09/18/20 Morgan Stanley
Facebook price target raised to $295 from $285 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
WMT Walmart
$135.30 /

-1.39 (-1.02%)

VLO Valero
$48.77 /

-0.23 (-0.47%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PSX Phillips 66
$59.83 /

-0.51 (-0.85%)

PFE Pfizer
$36.61 /

-0.2 (-0.54%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

HFC HollyFrontier
$22.00 /

-0.26 (-1.17%)

GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

DK Delek US
$11.89 /

-0.2 (-1.65%)

BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PSX Phillips 66
$59.83 /

-0.51 (-0.85%)

PFE Pfizer
$36.61 /

-0.2 (-0.54%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

HFC HollyFrontier
$22.00 /

-0.26 (-1.17%)

GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

DK Delek US
$11.89 /

-0.2 (-1.65%)

BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

VLO Valero
$48.77 /

-0.23 (-0.47%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

PFE Pfizer
$36.61 /

-0.2 (-0.54%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

WMT Walmart
$135.30 /

-1.39 (-1.02%)

VLO Valero
$48.77 /

-0.23 (-0.47%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

PSX Phillips 66
$59.83 /

-0.51 (-0.85%)

PFE Pfizer
$36.61 /

-0.2 (-0.54%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MPC Marathon Petroleum
$32.26 /

+0.14 (+0.44%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

JNJ Johnson & Johnson
$149.12 /

+2.03 (+1.38%)

GSK GlaxoSmithKline
$39.26 /

-0.2 (-0.51%)

FB Facebook
$252.53 /

-2.49 (-0.98%)

BMY Bristol-Myers
$59.26 /

-0.14 (-0.24%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.